Clinical trial
A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809
NCT00437840 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00437840 |
|---|---|
| Title | A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809 |
| Official title | A Placebo-controlled, Single-blind, Randomised, Human Volunteer Study Investigating the Tolerability and Pharmacokinetics of Escalating Single Oral Doses of GSK598809 in Smokers |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Substance Dependence |
| Intervention type | Drug |
| Interventions | GSK598809, Placebo |
| Enrollment | 12 |
| Start date | Mar 20, 2007 |
| Primary completion | Jun 20, 2007 |
| Completion | Jun 20, 2007 |
| First posted | Feb 21, 2007 |
| Last update posted | Aug 7, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: